SCHEMBL1018455

SCHEMBL1018455

CC(NC(=O)CCl)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SIGMAR1 Q99720 1/20 0.42
ALDH1A1 P00352 8/20 0.40
SMN1; SMN2 Q16637 7/20 0.40
LMNA P02545 5/20 0.40
HTT P42858 3/20 0.40
TAS1R3 Q7RTX0 3/20 0.39
TAS1R1 Q7RTX1 3/20 0.39
TAS1R2 Q8TE23 3/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.36
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1018454 1.00 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL18343317 0.80 ALDH1A1 (0.39) CYP3A4CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL31483043 0.79 CYP2C9 (0.46) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL16298847 0.79 CYP2C9 (0.46) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL15116375 0.77 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL13826479 0.77 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL8433156 0.77 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL25855749 0.77 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL23565702 0.77 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19SIGMAR1ALDH1A1
SCHEMBL11317431 0.76 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2LMNAHTTTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed